Asceneuron to present at Neurotech Investing and Partnering Conference

The Neurotech Investing and Partnering Conference is the premier partnering and investing conference for the neurotechnology industry, spanning pharmaceuticals, medical devices, software and diagnostics for the brain and nervous system. The Fourth Neurotech Investing and Partnering Conference Europe will take place at the Wyss Center, Campus Biotech, in Geneva, on October 3rd-4th, 2017.

Dr Dirk Beher will be presenter and panellist at the session "Treatment for Alzheimer's and Cognitive Disorders" on October 3rd, at 10:45 am. He will present O-Glcnacase Inhibitor ASN120290 as Anti-Tau Drug Candidate for Alzheimer’s Disease and Other Tauopathies.

Further information about the agenda: download PDF
Further information about the event: click here